Agilon Health AGL Available-for-Sale Debt Securities
Available-for-Sale Debt Securities at other companies
Other financials
Where this comes from
Reported directly by Agilon Health in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent.
The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agilon Health's available-for-sale debt securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agilon Health's available-for-sale debt securities?
- Agilon Health (AGL) reported available-for-sale debt securities of $91.42M in Q1 2026.
- How has Agilon Health's available-for-sale debt securities changed year-over-year?
- Agilon Health's available-for-sale debt securities decreased by 60.3% year-over-year, from $230.14M to $91.42M.
- What is the long-term trend for Agilon Health's available-for-sale debt securities?
- Over 3 years (2022 to 2025), Agilon Health's available-for-sale debt securities has grown at a -35.3% compound annual growth rate (CAGR), from $411.9M to $111.43M.
- What does available-for-sale debt securities mean?
- This represents investments in debt instruments that are classified as available-for-sale and are measured at fair value on the balance sheet. These securities are held as part of the company's treasury management strategy to generate returns on excess cash while maintaining liquidity. Changes in the fair value of these assets are recorded in other comprehensive income, reflecting the company's exposure to interest rate fluctuations and credit risk.